EP1263759B1
(fr)
|
1999-12-24 |
2010-09-08 |
Aventis Pharma Limited |
Azaindoles
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
EP2335700A1
(fr)
*
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Inhibiteurs de la polymerase du virus hepatitis C avec une structure heterobicylic
|
TWI329105B
(en)
*
|
2002-02-01 |
2010-08-21 |
Rigel Pharmaceuticals Inc |
2,4-pyrimidinediamine compounds and their uses
|
GB0202679D0
(en)
*
|
2002-02-05 |
2002-03-20 |
Glaxo Group Ltd |
Novel compounds
|
TW200307542A
(en)
|
2002-05-30 |
2003-12-16 |
Astrazeneca Ab |
Novel compounds
|
AU2003259749A1
(en)
|
2002-08-12 |
2004-02-25 |
Sugen, Inc. |
3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
|
SE0202463D0
(sv)
*
|
2002-08-14 |
2002-08-14 |
Astrazeneca Ab |
Novel compounds
|
US20050288299A1
(en)
*
|
2002-10-09 |
2005-12-29 |
Mavunkel Babu J |
Azaindole derivatives as inhibitors of p38 kinase
|
US7393851B2
(en)
*
|
2002-10-09 |
2008-07-01 |
Scios, Inc. |
Azaindole derivatives as inhibitors of p38 kinase
|
US20050043212A1
(en)
*
|
2002-10-09 |
2005-02-24 |
Ford Kirschenbaum |
Differential inhibition of p38 map kinase isoforms
|
US7098231B2
(en)
*
|
2003-01-22 |
2006-08-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
US7223785B2
(en)
|
2003-01-22 |
2007-05-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
GB0305142D0
(en)
*
|
2003-03-06 |
2003-04-09 |
Eisai London Res Lab Ltd |
Synthesis
|
SE0301372D0
(sv)
*
|
2003-05-09 |
2003-05-09 |
Astrazeneca Ab |
Novel compounds
|
EP1646382A4
(fr)
*
|
2003-06-30 |
2010-07-21 |
Hif Bio Inc |
Composes, compositions et procedes
|
US7202363B2
(en)
|
2003-07-24 |
2007-04-10 |
Abbott Laboratories |
Thienopyridine and furopyridine kinase inhibitors
|
BRPI0413018B8
(pt)
|
2003-07-30 |
2021-05-25 |
Rigel Pharmaceuticals Inc |
composto, e, uso de um composto
|
JP2007513184A
(ja)
|
2003-12-04 |
2007-05-24 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼのインヒビターとして有用なキノキサリン
|
US7572914B2
(en)
*
|
2003-12-19 |
2009-08-11 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
CN103304541A
(zh)
*
|
2004-02-20 |
2013-09-18 |
贝林格尔.英格海姆国际有限公司 |
病毒聚合酶抑制剂
|
US7507826B2
(en)
*
|
2004-03-30 |
2009-03-24 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of JAK and other protein kinases
|
FR2868422B1
(fr)
*
|
2004-03-31 |
2006-07-14 |
Aventis Pharma Sa |
Nouveaux derives pyrrolo(2,3-b) pyridine, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
JP2007531744A
(ja)
*
|
2004-04-05 |
2007-11-08 |
武田薬品工業株式会社 |
6−アザインドール化合物
|
JP2007533753A
(ja)
*
|
2004-04-23 |
2007-11-22 |
タケダ サン ディエゴ インコーポレイテッド |
インドール誘導体及びキナーゼ阻害剤としてのその使用
|
EP1781654A1
(fr)
*
|
2004-07-27 |
2007-05-09 |
SGX Pharmaceuticals, Inc. |
Modulateurs de kinases à base de pyrrolopyridine
|
AU2005266803B2
(en)
|
2004-07-30 |
2011-10-27 |
Methylgene Inc. |
Inhibitors of VEGF receptor and HGF receptor signaling
|
EP1797054A2
(fr)
*
|
2004-08-02 |
2007-06-20 |
OSI Pharmaceuticals, Inc. |
Composes a base de pyrrolopyrimidine a substitution arylamine inhibiteurs de kinases multiples
|
WO2006023931A2
(fr)
*
|
2004-08-18 |
2006-03-02 |
Takeda San Diego, Inc. |
Inhibiteurs de kinase
|
CA2578075A1
(fr)
*
|
2004-08-26 |
2006-03-02 |
Pfizer Inc. |
Composes aminoheteroaryles en tant qu'inhibiteurs des proteines tyrosine kinases
|
FR2876103B1
(fr)
*
|
2004-10-01 |
2008-02-22 |
Aventis Pharma Sa |
Nouveaux derives bis-azaindoles, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
|
JP2008516973A
(ja)
|
2004-10-15 |
2008-05-22 |
タケダ サン ディエゴ インコーポレイテッド |
キナーゼ阻害剤
|
MY179032A
(en)
*
|
2004-10-25 |
2020-10-26 |
Cancer Research Tech Ltd |
Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
|
WO2006058120A1
(fr)
*
|
2004-11-22 |
2006-06-01 |
Vertex Pharmaceuticals Incorporated |
Inhibiteurs bicycliques de rho kinase
|
WO2006063167A1
(fr)
*
|
2004-12-08 |
2006-06-15 |
Smithkline Beecham Corporation |
1h -pyrrolo[2,3-b]pyridines
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
US7786113B2
(en)
*
|
2004-12-23 |
2010-08-31 |
Hoffman-La Roche Inc. |
Heterocyclic carbamate derivatives, their manufacture and use as pharmaceutical agents
|
CA2605738C
(fr)
|
2005-04-25 |
2013-10-01 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Nouveaux aza-heterocycles constituant des inhibiteurs de kinases
|
FR2884821B1
(fr)
*
|
2005-04-26 |
2007-07-06 |
Aventis Pharma Sa |
Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
|
WO2008041053A2
(fr)
|
2005-05-20 |
2008-04-10 |
Methylgene, Inc. |
Inhibiteurs de la signalisation du récepteur vegf et du récepteur hgf
|
CN101228161B
(zh)
*
|
2005-05-20 |
2012-10-10 |
沃泰克斯药物股份有限公司 |
适用作蛋白激酶抑制剂的吡咯并吡啶类
|
NZ563774A
(en)
|
2005-05-20 |
2010-04-30 |
Methylgene Inc |
Inhibitors of VEGF receptor and HGF receptor signaling
|
US7576053B2
(en)
|
2005-06-13 |
2009-08-18 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions for treating degenerative bone disorders
|
PT1734251E
(pt)
*
|
2005-06-17 |
2007-03-30 |
Magneti Marelli Powertrain Spa |
Injector de combustível
|
WO2007002325A1
(fr)
*
|
2005-06-22 |
2007-01-04 |
Plexxikon, Inc. |
Composes et methodes de modulation de la kinase et instructions afferentes
|
KR101142363B1
(ko)
*
|
2005-06-27 |
2012-05-21 |
주식회사유한양행 |
피롤로피리딘 유도체를 포함하는 항암제 조성물
|
CA2618682C
(fr)
*
|
2005-08-12 |
2011-06-21 |
Boehringer Ingelheim International Gmbh |
Inhibiteurs de polymerase virale
|
US8119655B2
(en)
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
WO2007044804A2
(fr)
|
2005-10-11 |
2007-04-19 |
Chemocentryx, Inc. |
Derives de piperidine et leurs procedes d'utilisation
|
US7371862B2
(en)
|
2005-11-11 |
2008-05-13 |
Pfizer Italia S.R.L. |
Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
US8017781B2
(en)
|
2005-11-15 |
2011-09-13 |
Vertex Pharmaceuticals Incorporated |
Azaindazoles useful as inhibitors of kinases
|
WO2007067537A1
(fr)
*
|
2005-12-07 |
2007-06-14 |
Osi Pharmaceuticals, Inc. |
Composés inhibant les pyrrolopyridine kinases
|
CN103214483B
(zh)
|
2005-12-13 |
2014-12-17 |
因塞特公司 |
作为两面神激酶抑制剂的杂芳基取代的吡咯并[2,3-b]吡啶和吡咯并[2,3-b]嘧啶
|
WO2007078335A2
(fr)
*
|
2005-12-21 |
2007-07-12 |
Decode Genetics, Ehf. |
Inhibiteurs de biaryl-azote-heterocycle de lta4h pour traiter l'inflammation
|
AU2007207533B8
(en)
|
2006-01-17 |
2012-06-28 |
Vertex Pharmaceuticals Incorporated |
Azaindoles useful as inhibitors of Janus kinases
|
DK2010493T3
(en)
*
|
2006-04-12 |
2016-05-02 |
Merck Sharp & Dohme |
PYRIDYLAMIDE T-TYPE CALCIUM CHANNEL ANTAGONISTS
|
EP2026775B1
(fr)
*
|
2006-05-09 |
2015-04-29 |
Novaremed Ltd. |
Utilisations des inhibiteurs de tyrosine kinase syk pour le traitement de troubles cellulaires proliferatifs
|
EP2027087A2
(fr)
*
|
2006-05-18 |
2009-02-25 |
MannKind Corporation |
Inhibiteurs de kinases intracellulaires
|
GB0617161D0
(en)
*
|
2006-08-31 |
2006-10-11 |
Vernalis R&D Ltd |
Enzyme inhibitors
|
CL2007002617A1
(es)
|
2006-09-11 |
2008-05-16 |
Sanofi Aventis |
Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.
|
EP2223925A1
(fr)
*
|
2006-10-09 |
2010-09-01 |
Takeda Pharmaceutical Company Limited |
Inhibiteurs de kinase
|
US20100120717A1
(en)
|
2006-10-09 |
2010-05-13 |
Brown Jason W |
Kinase inhibitors
|
WO2008063888A2
(fr)
*
|
2006-11-22 |
2008-05-29 |
Plexxikon, Inc. |
Composés modulant l'activité de c-fms et/ou de c-kit et utilisations associées
|
JP5406039B2
(ja)
|
2006-12-21 |
2014-02-05 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
タンパク質キナーゼ阻害剤として有用な5−シアノ−4−(ピロロ[2,3b]ピリジン−3−イル)−ピリミジン誘導体
|
PE20121126A1
(es)
*
|
2006-12-21 |
2012-08-24 |
Plexxikon Inc |
Compuestos pirrolo [2,3-b] piridinas como moduladores de quinasa
|
US20090068110A1
(en)
*
|
2006-12-22 |
2009-03-12 |
Genentech, Inc. |
Antibodies to insulin-like growth factor receptor
|
US8293781B2
(en)
|
2007-03-29 |
2012-10-23 |
Daiichi Sankyo Company, Limited |
Indole derivatives having cPLA2 inhibiting activity and applications and production methods of the same
|
KR101549876B1
(ko)
|
2007-06-13 |
2015-09-03 |
인사이트 코포레이션 |
야누스 키나제 억제제(R)―3―(4―(7H―피롤로[2,3-d]피리미딘―4―일)―1H―피라졸―1―일)―3―사이클로펜틸프로판니트릴의 염
|
JP2010533729A
(ja)
|
2007-07-17 |
2010-10-28 |
プレキシコン,インコーポレーテッド |
キナーゼ調節のための化合物と方法、及びそのための適応
|
US20110160232A1
(en)
|
2007-10-04 |
2011-06-30 |
Pingda Ren |
Certain chemical entities and therapeutic uses thereof
|
KR20100072266A
(ko)
|
2007-10-24 |
2010-06-30 |
머크 샤프 앤드 돔 코포레이션 |
헤테로사이클 페닐 아미드 t-형 칼슘 채널 길항제
|
CA2702126A1
(fr)
*
|
2007-10-24 |
2009-04-30 |
Merck Sharp & Dohme Corp. |
Antagonistes des canaux calciques de type t a base d'amide heterocyclique
|
WO2009106445A1
(fr)
*
|
2008-02-25 |
2009-09-03 |
F. Hoffmann-La Roche Ag |
Inhibiteurs de kinase pyrrolopyrazine
|
PT2247592E
(pt)
|
2008-02-25 |
2011-11-03 |
Hoffmann La Roche |
Inibidores de pirrolpirazina-cinase
|
AU2009218609A1
(en)
|
2008-02-25 |
2009-09-03 |
F. Hoffmann-La Roche Ag |
Pyrrolopyrazine kinase inhibitors
|
JP5529049B2
(ja)
|
2008-02-25 |
2014-06-25 |
エフ.ホフマン−ラ ロシュ アーゲー |
ピロロピラジンキナーゼ阻害剤
|
CA2713324A1
(fr)
|
2008-02-25 |
2009-09-03 |
F. Hoffmann-La Roche Ag |
Inhibiteurs de la pyrrolopyrazine kinase
|
CN102015723B
(zh)
|
2008-03-05 |
2014-07-30 |
梅特希尔基因公司 |
蛋白酪氨酸激酶活性的抑制剂
|
WO2009114874A2
(fr)
|
2008-03-14 |
2009-09-17 |
Intellikine, Inc. |
Inhibiteurs de kinases (benzothiazole) et procédés d’utilisation associés
|
JP5547099B2
(ja)
|
2008-03-14 |
2014-07-09 |
インテリカイン, エルエルシー |
キナーゼ阻害剤および使用方法
|
US9273077B2
(en)
|
2008-05-21 |
2016-03-01 |
Ariad Pharmaceuticals, Inc. |
Phosphorus derivatives as kinase inhibitors
|
DK2300013T3
(en)
|
2008-05-21 |
2017-12-04 |
Ariad Pharma Inc |
PHOSPHORUS DERIVATIVES AS KINASE INHIBITORS
|
WO2009152083A1
(fr)
*
|
2008-06-10 |
2009-12-17 |
Plexxikon, Inc. |
Dérivés 5h-pyrrolo-[2,3-b]-pyrazine destinés à la modulation de kinases, et des indications pour ceux-ci
|
JP5788316B2
(ja)
*
|
2008-07-08 |
2015-09-30 |
インテリカイン, エルエルシー |
キナーゼインヒビターおよび使用方法
|
US8476282B2
(en)
|
2008-11-03 |
2013-07-02 |
Intellikine Llc |
Benzoxazole kinase inhibitors and methods of use
|
EP2365809B8
(fr)
|
2008-11-12 |
2018-10-10 |
Ariad Pharmaceuticals, Inc. |
Pyrazinopyrazines et dérivés utiles comme inhibiteurs de kinases
|
BRPI0921392A2
(pt)
|
2008-12-05 |
2016-04-26 |
Abbott Lab |
inibidores quinase com perfil de segurança cyp aperfeiçoado
|
MX2011005597A
(es)
*
|
2008-12-05 |
2011-06-16 |
Hoffmann La Roche |
Pirrolopirazinil-ureas como inhibidores de cinasas.
|
AU2009325072A1
(en)
|
2008-12-12 |
2011-06-30 |
Ariad Pharmaceuticals, Inc. |
Azaindole derivatives as kinase inhibitors
|
MY173940A
(en)
*
|
2009-02-25 |
2020-02-28 |
Takeda Pharmaceuticals Co |
Process for producing pyrrole compound
|
US20110112101A1
(en)
*
|
2009-03-05 |
2011-05-12 |
Sanofi-Aventis |
Treatment for ocular-related disorders
|
MX2011008303A
(es)
*
|
2009-04-03 |
2011-11-29 |
Plexxikon Inc |
Composiciones del acido propano-1-sulfonico {3-[5-(4-cloro-fenil)- 1h-pirrolo [2,3-b]-piridina-3-carbonil]-2,4-difluoro-fenil}-amida y el uso de las mismas.
|
WO2010135411A2
(fr)
*
|
2009-05-19 |
2010-11-25 |
The Regents Of The University Of Colorado |
Nombre de copies d'aurora a et sensibilité aux inhibiteurs
|
WO2010146059A2
(fr)
|
2009-06-16 |
2010-12-23 |
F. Hoffmann-La Roche Ag |
Biomarqueurs pour une thérapie par inhibiteur d'igf-1r
|
GEP20207129B
(en)
|
2009-06-17 |
2020-07-10 |
Vertex Pharma |
Inhibitors of influenza viruses replication
|
US8329724B2
(en)
|
2009-08-03 |
2012-12-11 |
Hoffmann-La Roche Inc. |
Process for the manufacture of pharmaceutically active compounds
|
FR2949467B1
(fr)
|
2009-09-03 |
2011-11-25 |
Sanofi Aventis |
Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
|
PE20121327A1
(es)
|
2009-11-06 |
2012-10-18 |
Plexxikon Inc |
Compuestos y metodos para la modulacion de cinasas, e indicaciones para ello
|
EP2338890A1
(fr)
|
2009-12-22 |
2011-06-29 |
Bayer CropScience AG |
Dérivés de 4,7-diazaindole et leur utilisation en tant que fongicides
|
ME02186B
(me)
|
2009-12-23 |
2016-02-20 |
Takeda Pharmaceuticals Co |
Fuzionisani heteroaromatski pirolidinoni kao syk inhibitori
|
EP2550272A1
(fr)
*
|
2010-01-27 |
2013-01-30 |
Vertex Pharmaceuticals Incorporated |
Inhibiteurs de la pyrazolopyrazine kinase
|
WO2011109932A1
(fr)
*
|
2010-03-09 |
2011-09-15 |
F.Hoffmann-La Roche Ag |
Nouveau procédé pour la fabrication de 7-azaindoles 5-halogénés
|
TWI766281B
(zh)
|
2010-03-10 |
2022-06-01 |
美商英塞特控股公司 |
作為jak1抑制劑之哌啶-4-基三亞甲亞胺衍生物
|
US8481541B2
(en)
|
2010-03-22 |
2013-07-09 |
Hoffmann-La Roche Inc. |
Pyrrolopyrazine kinase inhibitors
|
US8518945B2
(en)
|
2010-03-22 |
2013-08-27 |
Hoffmann-La Roche Inc. |
Pyrrolopyrazine kinase inhibitors
|
BR112012029437A2
(pt)
*
|
2010-05-20 |
2017-03-07 |
F Hoffmann - La Roche Ag |
derivados de pirrolo[2,3-b]pirazina-7-carboxamida e seu uso como inibidores de jak e syk
|
RU2012152354A
(ru)
|
2010-05-20 |
2014-06-27 |
Ф. Хоффманн-Ля Рош Аг |
Производные пирролопиразина в качестве ингибиторов syk и jak
|
CN103002875B
(zh)
|
2010-05-21 |
2016-05-04 |
因塞特控股公司 |
Jak抑制剂的局部用制剂
|
JP6086326B2
(ja)
*
|
2010-05-24 |
2017-03-01 |
ユニヴァーシティー オブ ロチェスター |
二環式ヘテロアリールキナーゼ阻害剤および使用方法
|
US9265739B2
(en)
|
2010-06-02 |
2016-02-23 |
The Trustees Of The University Of Pennsylvania |
Methods and use of compounds that bind to HER2/neu receptor complex
|
US8993634B2
(en)
|
2010-06-02 |
2015-03-31 |
The Trustees Of The University Of Pennsylvania |
Methods and use of compounds that bind to Her2/neu receptor complex
|
CA2816219C
(fr)
*
|
2010-11-01 |
2019-10-29 |
Portola Pharmaceuticals, Inc. |
Nicotinamides comme modulateurs syk
|
TW201249845A
(en)
|
2010-11-19 |
2012-12-16 |
Incyte Corp |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors
|
AU2011343642A1
(en)
|
2010-12-16 |
2013-05-02 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
US8754114B2
(en)
|
2010-12-22 |
2014-06-17 |
Incyte Corporation |
Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
|
RS58455B1
(sr)
|
2011-02-07 |
2019-04-30 |
Plexxikon Inc |
Jedinjenja i postupci za modulaciju kinaze, i indikacije za njih
|
AR085279A1
(es)
|
2011-02-21 |
2013-09-18 |
Plexxikon Inc |
Formas solidas de {3-[5-(4-cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico
|
AR085397A1
(es)
|
2011-02-23 |
2013-09-25 |
Intellikine Inc |
Combinacion de inhibidores de quinasa y sus usos
|
WO2012151561A1
(fr)
|
2011-05-04 |
2012-11-08 |
Ariad Pharmaceuticals, Inc. |
Composés permettant d'inhiber la prolifération cellulaire dans les cancers induits par l'egfr
|
US9290490B2
(en)
|
2011-05-10 |
2016-03-22 |
Merck Sharp & Dohme Corp. |
Aminopyrimidines as Syk inhibitors
|
US9145391B2
(en)
|
2011-05-10 |
2015-09-29 |
Merck Sharp & Dohme Corp. |
Bipyridylaminopyridines as Syk inhibitors
|
CA2834062A1
(fr)
|
2011-05-10 |
2012-11-15 |
Merck Sharp & Dohme Corp. |
Pyridylaminopyridines en tant qu'inhibiteurs de syk
|
WO2012177606A1
(fr)
|
2011-06-20 |
2012-12-27 |
Incyte Corporation |
Dérivés d'azétidinyl-phényl-, de pyridyl- ou de pyrazinyl-carboxamide en tant qu'inhibiteurs des jak
|
JP6026525B2
(ja)
|
2011-06-22 |
2016-11-16 |
武田薬品工業株式会社 |
置換6−アザ−イソインドリン−1−オン誘導体
|
KR20140058547A
(ko)
|
2011-07-05 |
2014-05-14 |
버텍스 파마슈티칼스 인코포레이티드 |
아자인돌을 제조하기 위한 방법 및 중간체
|
WO2013012909A1
(fr)
|
2011-07-20 |
2013-01-24 |
Abbott Laboratories |
Inhibiteur de kinase ayant une solubilité améliorée dans l'eau
|
UA118010C2
(uk)
|
2011-08-01 |
2018-11-12 |
Вертекс Фармасьютікалз Інкорпорейтед |
Інгібітори реплікації вірусів грипу
|
DE102011111400A1
(de)
*
|
2011-08-23 |
2013-02-28 |
Merck Patent Gmbh |
Bicyclische heteroaromatische Verbindungen
|
ME03332B
(fr)
|
2011-09-14 |
2019-10-20 |
Samumed Llc |
Indazole-3-carboxamides et leur utilisation en tant qu'inhibiteurs de la voie de signalisation par wnt/ -caténine
|
WO2013052394A1
(fr)
|
2011-10-05 |
2013-04-11 |
Merck Sharp & Dohme Corp. |
Inhibiteurs de tyrosine kinase de la rate (syk) contenant un 2-pyridyl carboxamide
|
WO2013052391A1
(fr)
|
2011-10-05 |
2013-04-11 |
Merck Sharp & Dohme Corp. |
Inhibiteurs de tyrosine kinase de la rate (syk) contenant un phényl carboxamide
|
EP2763975B1
(fr)
|
2011-10-05 |
2016-04-06 |
Merck Sharp & Dohme Corp. |
Inhibiteurs de tyrosine kinase de la rate (syk) contenant un 3-pyridyl carboxamide
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
AU2013250726B2
(en)
|
2012-04-20 |
2017-01-05 |
Advinus Therapeutics Limited |
Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof
|
WO2013169401A1
(fr)
|
2012-05-05 |
2013-11-14 |
Ariad Pharmaceuticals, Inc. |
Composés pour inhiber la prolifération cellulaire dans les cancers induits par l'egfr
|
US9150570B2
(en)
|
2012-05-31 |
2015-10-06 |
Plexxikon Inc. |
Synthesis of heterocyclic compounds
|
DK3176170T3
(en)
|
2012-06-13 |
2019-01-28 |
Incyte Holdings Corp |
SUBSTITUTED TRICYCLIC RELATIONS AS FGFR INHIBITORS
|
EP2863914B1
(fr)
|
2012-06-20 |
2018-10-03 |
Merck Sharp & Dohme Corp. |
Dérivés de pyrazolyle en tant qu'inhibiteurs de syk
|
WO2013192128A1
(fr)
|
2012-06-20 |
2013-12-27 |
Merck Sharp & Dohme Corp. |
Analogues d'imidazolyle en tant qu'inhibiteurs de syk
|
EP2863916B1
(fr)
|
2012-06-22 |
2018-07-18 |
Merck Sharp & Dohme Corp. |
Inhibiteurs à pyridine substituée de la tyrosine kinase de la rate (syk)
|
WO2013192088A1
(fr)
|
2012-06-22 |
2013-12-27 |
Merck Sharp & Dohme Corp. |
Inhibiteurs de tyrosine kinase splénique (syk) diazines et triazines substituées
|
CN102718694B
(zh)
*
|
2012-06-27 |
2014-04-02 |
上海大学 |
3-氰基取代吲哚化合物及其合成方法
|
US9388185B2
(en)
|
2012-08-10 |
2016-07-12 |
Incyte Holdings Corporation |
Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
|
WO2014031438A2
(fr)
|
2012-08-20 |
2014-02-27 |
Merck Sharp & Dohme Corp. |
Inhibiteurs de la phényle tyrosine kinase de la rate (syk) substitués
|
SG10202111768XA
(en)
|
2012-11-15 |
2021-11-29 |
Incyte Holdings Corp |
Sustained-release dosage forms of ruxolitinib
|
EP2738172A1
(fr)
*
|
2012-11-28 |
2014-06-04 |
Almirall, S.A. |
Nouveaux composés bicycliques utilisés comme modulateurs du canal crac
|
US9266892B2
(en)
|
2012-12-19 |
2016-02-23 |
Incyte Holdings Corporation |
Fused pyrazoles as FGFR inhibitors
|
EP2943198B1
(fr)
|
2013-01-08 |
2019-07-17 |
Samumed, LLC |
Inhibiteurs de 3-(benzoimidazol-2-yl)-indazole de la voie de signalisation par wnt et leurs utilisations thérapeutiques
|
US9468681B2
(en)
|
2013-03-01 |
2016-10-18 |
California Institute Of Technology |
Targeted nanoparticles
|
LT2964650T
(lt)
|
2013-03-06 |
2019-04-25 |
Incyte Holdings Corporation |
Būdai ir tarpiniai junginiai, skirti jak inhibitoriaus gamybai
|
RS59411B1
(sr)
|
2013-03-13 |
2019-11-29 |
Forma Therapeutics Inc |
Derivati 2-hidroksi-1-{4-[(4-fenilfenil)karbonil]piperazin-1-il}etan-1-ona i srodna jedinjenja kao inhibitori sintaze masnih kiselina (fasn) za lečenje kancera
|
AU2014231567A1
(en)
|
2013-03-14 |
2015-10-01 |
Abbvie Inc. |
Pyrrolo[2,3-b]pyridine CDK9 kinase inhibitors
|
TW201446763A
(zh)
*
|
2013-03-14 |
2014-12-16 |
Abbvie Inc |
吡咯并[2,3-b]吡啶cdk9激酶抑制劑
|
US9611283B1
(en)
|
2013-04-10 |
2017-04-04 |
Ariad Pharmaceuticals, Inc. |
Methods for inhibiting cell proliferation in ALK-driven cancers
|
SI2986610T1
(en)
|
2013-04-19 |
2018-04-30 |
Incyte Holdings Corporation |
Bicyclic heterocycles as inhibitors of FGFR
|
SI3030227T1
(sl)
|
2013-08-07 |
2020-08-31 |
Incyte Corporation |
Dozirne oblike s podaljšanim sproščanjem za inhibitor JAK1
|
JPWO2015029447A1
(ja)
*
|
2013-08-30 |
2017-03-02 |
興和株式会社 |
光学活性カルビノール化合物の製造方法
|
DK3068776T3
(da)
|
2013-11-13 |
2019-07-29 |
Vertex Pharma |
Inhibitorer af replikation af influenzavira
|
SI3068782T1
(sl)
|
2013-11-13 |
2018-10-30 |
Vertex Pharmaceuticals Incorporated |
Postopki za pripravo inhibitorjev v replikacije virusov gripe
|
WO2016040190A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine et ses utilisations thérapeutiques
|
WO2016040180A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine et ses utilisations thérapeutiques
|
WO2016040184A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine et ses utilisations thérapeutiques
|
WO2016040193A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine et ses utilisations thérapeutiques
|
WO2016040185A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine et ses utilisations thérapeutiques
|
WO2016040181A1
(fr)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine et ses utilisations thérapeutiques
|
US10851105B2
(en)
|
2014-10-22 |
2020-12-01 |
Incyte Corporation |
Bicyclic heterocycles as FGFR4 inhibitors
|
CA2970185C
(fr)
|
2014-12-11 |
2023-10-17 |
Beta Pharma, Inc. |
Derives de 2-anilinopyrimidine substitues utilises comme modulateurs de l'egfr
|
WO2016134294A1
(fr)
|
2015-02-20 |
2016-08-25 |
Incyte Corporation |
Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
|
EP3617205B1
(fr)
|
2015-02-20 |
2021-08-04 |
Incyte Corporation |
Hétérocycles bicycliques utilisés comme inhibiteurs des fgfr
|
MA41551A
(fr)
|
2015-02-20 |
2017-12-26 |
Incyte Corp |
Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
|
MA42422A
(fr)
|
2015-05-13 |
2018-05-23 |
Vertex Pharma |
Inhibiteurs de la réplication des virus de la grippe
|
WO2016183116A1
(fr)
|
2015-05-13 |
2016-11-17 |
Vertex Pharmaceuticals Incorporated |
Procédés de préparation d'inhibiteurs de réplication des virus de la grippe
|
CN111643479B
(zh)
|
2015-07-01 |
2023-10-27 |
加州理工学院 |
基于阳离子粘酸聚合物的递送系统
|
US10519169B2
(en)
|
2015-08-03 |
2019-12-31 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10226453B2
(en)
|
2015-08-03 |
2019-03-12 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10285983B2
(en)
|
2015-08-03 |
2019-05-14 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-B] pyridines and therapeutic uses thereof
|
WO2017023987A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines et leurs utilisations thérapeutiques
|
US10188634B2
(en)
|
2015-08-03 |
2019-01-29 |
Samumed, Llc |
3-(3H-imidazo[4,5-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
WO2017024010A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-indazoles et leurs utilisations thérapeutiques
|
WO2017023986A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-indol-2-yl)-1h-indazoles et leurs utilisations thérapeutiques
|
US10350199B2
(en)
|
2015-08-03 |
2019-07-16 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
US10206908B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
WO2017023980A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines et leurs utilisations thérapeutiques
|
WO2017023972A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines et leurs utilisations thérapeutiques
|
WO2017024003A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines et leurs utilisations thérapeutiques
|
WO2017023975A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines et leus utilisations thérapeutiques
|
US10329309B2
(en)
|
2015-08-03 |
2019-06-25 |
Samumed, Llc |
3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10166218B2
(en)
|
2015-08-03 |
2019-01-01 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
US10206909B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
WO2017023989A1
(fr)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[4,3-b]pyridines et leurs utilisations thérapeutiques
|
US10426758B2
(en)
*
|
2015-10-13 |
2019-10-01 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Sibiriline derivatives for use for preventing and/or treating disorders associated with cellular necroptosis
|
US10544139B2
(en)
|
2015-11-06 |
2020-01-28 |
Samumed, Llc |
Treatment of osteoarthritis
|
WO2017100201A1
(fr)
*
|
2015-12-07 |
2017-06-15 |
Plexxikon Inc. |
Composés et procédés pour la modulation de kinase, et indications associées
|
AR107030A1
(es)
*
|
2015-12-09 |
2018-03-14 |
Padlock Therapeutics Inc |
Inhibidores aza-bencimidazol de pad4
|
US20190060286A1
(en)
|
2016-02-29 |
2019-02-28 |
University Of Florida Research Foundation, Incorpo |
Chemotherapeutic Methods
|
CA3026076A1
(fr)
|
2016-06-01 |
2017-12-07 |
Samumed, Llc |
Procede de preparation de n-(5-(3-(7-(3-fluorophenyl))-3 h-imidazo[4,5-c]pyridin-2-yl)-1h-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide
|
CN106008306A
(zh)
*
|
2016-06-28 |
2016-10-12 |
山东大学 |
取代吲哚类衍生物及其制备方法与应用
|
MX2019004616A
(es)
|
2016-10-21 |
2019-11-21 |
Samumed Llc |
Métodos de uso de indazol-3-carboxamidas y su uso como inhibidores de la ruta de señalización de wnt/b-catenina.
|
MA46696A
(fr)
|
2016-11-07 |
2019-09-11 |
Samumed Llc |
Formulations injectables à dose unique prêtes à l'emploi
|
AR111960A1
(es)
|
2017-05-26 |
2019-09-04 |
Incyte Corp |
Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
|
US10428067B2
(en)
|
2017-06-07 |
2019-10-01 |
Plexxikon Inc. |
Compounds and methods for kinase modulation
|
US10596161B2
(en)
|
2017-12-08 |
2020-03-24 |
Incyte Corporation |
Low dose combination therapy for treatment of myeloproliferative neoplasms
|
MX2020007973A
(es)
|
2018-01-30 |
2020-12-07 |
Incyte Corp |
Procesos para preparar (1-(3-fluoro-2-(trifluorometil)isonicotinil )piperidin-4-ona).
|
UA127925C2
(uk)
|
2018-03-30 |
2024-02-14 |
Інсайт Корпорейшн |
Лікування гнійного гідраденіту з використанням інгібіторів jak
|
CN108358894B
(zh)
*
|
2018-04-26 |
2021-05-07 |
四川大学 |
一种抑制组蛋白乙酰转移酶的化合物及其制备方法与应用
|
AU2019262579A1
(en)
|
2018-05-04 |
2020-12-24 |
Incyte Corporation |
Salts of an FGFR inhibitor
|
BR112020022392A2
(pt)
|
2018-05-04 |
2021-02-02 |
Incyte Corporation |
formas sólidas de um inibidor de fgfr e processos para preparação das mesmas
|
JP7483193B2
(ja)
|
2018-06-13 |
2024-05-15 |
カリフォルニア・インスティテュート・オブ・テクノロジー |
血脳バリアを越えるためのナノ粒子とそれを用いた治療法
|
TWI767148B
(zh)
|
2018-10-10 |
2022-06-11 |
美商弗瑪治療公司 |
抑制脂肪酸合成酶(fasn)
|
CN113382633A
(zh)
|
2018-10-29 |
2021-09-10 |
福马治疗股份有限公司 |
(4-(2-氟-4-(1-甲基-1H-苯并[d]咪唑-5-基)苯甲酰基)哌嗪-1-基)(1-羟基环丙基)甲酮的固体形式
|
WO2020132384A1
(fr)
|
2018-12-21 |
2020-06-25 |
Celgene Corporation |
Inhibiteurs thiénopyridine de ripk2
|
BR112021011578A2
(pt)
|
2018-12-31 |
2021-08-31 |
Biomea Fusion, Llc |
Inibidores irreversíveis de interação menina-mll
|
TW202043205A
(zh)
|
2018-12-31 |
2020-12-01 |
美商拜歐米富士恩有限公司 |
Menin-mll相互作用之抑制劑
|
US20220073494A1
(en)
*
|
2019-01-31 |
2022-03-10 |
Kyorin Pharmaceutical Co., Ltd. |
15-pgdh inhibitors
|
WO2020185532A1
(fr)
|
2019-03-08 |
2020-09-17 |
Incyte Corporation |
Méthodes de traitement du cancer au moyen d'un inhibiteur de fgfr
|
CN111171001B
(zh)
*
|
2019-05-16 |
2022-04-29 |
百济神州(苏州)生物科技有限公司 |
一种parp抑制剂中间体的结晶方法
|
US11591329B2
(en)
|
2019-07-09 |
2023-02-28 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
WO2021076602A1
(fr)
|
2019-10-14 |
2021-04-22 |
Incyte Corporation |
Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr
|
US11566028B2
(en)
|
2019-10-16 |
2023-01-31 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
JP2023505258A
(ja)
|
2019-12-04 |
2023-02-08 |
インサイト・コーポレイション |
Fgfr阻害剤としての三環式複素環
|
JP2023505257A
(ja)
|
2019-12-04 |
2023-02-08 |
インサイト・コーポレイション |
Fgfr阻害剤の誘導体
|
US12012409B2
(en)
|
2020-01-15 |
2024-06-18 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
AU2021214148A1
(en)
*
|
2020-01-30 |
2022-07-14 |
Anima Biotech Inc. |
Collagen 1 translation inhibitors and methods of use thereof
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
EP4352059A1
(fr)
|
2021-06-09 |
2024-04-17 |
Incyte Corporation |
Hétérocycles tricycliques en tant qu'inhibiteurs de fgfr
|
CA3229150A1
(fr)
|
2021-08-20 |
2023-02-23 |
Biomea Fusion, Inc. |
Formes cristallines de n-[4-[4-(4-morpholinyl)-7h-pyrrolo[2,3-d]pyrimidine-6-yl]phenyl]-4-[[3(r)-[(1-oxo-2-propene-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide, un inhibiteur irreversible de menine-mll pour le traitement du cance
|
WO2024026500A2
(fr)
*
|
2022-07-28 |
2024-02-01 |
University Of Maryland, Baltimore |
Inhibiteurs de pde11a4 et leurs méthodes d'utilisation
|